Harnessing PPAR pharmacology through dual incretin-directed delivery.

Cell Metabolism · 2 June 2026 · Comment

Petersen, Clemmensen

The abstract is read at the publisher; the summary is JClub's.

A unimolecular conjugate was engineered to act as a quintuple agonist, combining GLP-1R/GIPR co-agonism with pan-PPAR activation to link incretin signaling to PPAR transcriptional control.

Why it matters: Separate incretin and PPAR pathways are often targeted independently, leaving a gap in coordinated control of incretin-driven signaling and PPAR-mediated gene regulation within one therapeutic design.
What they did: Liskiewicz et al. describe a single therapeutic scaffold that couples GLP-1R/GIPR co-agonism with pan-PPAR nuclear receptor activation in one unimolecular conjugate.
The result: The approach enables incretin signaling and PPAR-mediated transcriptional control to be coordinated within a single molecular construct, supporting a unified pharmacology strategy.

AI summary of the abstract · may contain errors · not medical advice · read the paper.

Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.

Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy.
Nature Immunology · 1 Nov 2026 · Journal Article
AI summary · may contain errors
Activating PPARδ in immune cells, but not cancer cells, shifts cancer–immune fitness balance and improves immunotherapy efficacy, including sensitizing immunotherapy-resistant microsatellite stable metastatic colorectal cancer in mice.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42875546
Open in JClub
PPAR/RXR dysregulation involved in hepatic lipid accumulation in HFPO-TeA-exposed zebrafish: Insights from multi-omics and spatial imaging.
Environmental Research · 31 Oct 2026 · Journal Article
AI summary · may contain errors
HFPO-TeA exposure in adult zebrafish causes steatosis-like hepatic injury linked to a PPAR/RXR dysregulation pattern, including pparg upregulation and RXR down-regulation.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42966525
Open in JClub
MTAP loss upregulates BCAT1 in pancreatic cancer and drives branched-chain amino acid dependency.
Cell Reports · 27 Oct 2026 · Journal Article
AI summary · may contain errors
MTAP loss in pancreatic ductal adenocarcinoma is linked to increased BCAT1 expression, creating a branched-chain amino acid dependency that supports aggressive tumor metabolism.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42814576
Open in JClub

Journals this month

All journals →

Topics moving, week to 13 Nov 2026

All topics →

By field

All journals by field →

Harnessing PPAR pharmacology through dual incretin-directed delivery.

Related in JClub

Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy.

PPAR/RXR dysregulation involved in hepatic lipid accumulation in HFPO-TeA-exposed zebrafish: Insights from multi-omics and spatial imaging.

MTAP loss upregulates BCAT1 in pancreatic cancer and drives branched-chain amino acid dependency.

Browse JClub